Bone

Papers
(The H4-Index of Bone is 35. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Bone regeneration is mediated by macrophage extracellular vesicles109
Re-thinking the bone remodeling cycle mechanism and the origin of bone loss88
Deep learning of lumbar spine X-ray for osteopenia and osteoporosis screening: A multicenter retrospective cohort study84
The role of bone morphogenetic protein signaling in vascular calcification79
Epidemiology of bone metastases74
Mettl3 inhibits the apoptosis and autophagy of chondrocytes in inflammation through mediating Bcl2 stability via Ythdf1-mediated m6A modification68
The effect of exercise intensity on bone in postmenopausal women (part 2): A meta-analysis66
Biological functions of chromobox (CBX) proteins in stem cell self-renewal, lineage-commitment, cancer and development59
RANKL biology58
Recent approaches towards bone tissue engineering55
Intracellular Staphylococcus aureus in bone and joint infections: A mechanism of disease recurrence, inflammation, and bone and cartilage destruction52
Discovery of bone morphogenetic proteins – A historical perspective52
A randomized pilot study using calcitriol in hospitalized COVID-19 patients51
Irisin inhibits osteocyte apoptosis by activating the Erk signaling pathway in vitro and attenuates ALCT-induced osteoarthritis in mice49
Hypophosphatemia after intravenous iron therapy: Comprehensive review of clinical findings and recommendations for management49
The role of microRNAs in bone development46
The Wnt pathway: An important control mechanism in bone's response to mechanical loading46
Lipid metabolism in sarcopenia45
PDGF-BB exhibited therapeutic effects on rat model of bisphosphonate-related osteonecrosis of the jaw by enhancing angiogenesis and osteogenesis44
Bisphosphonates: The role of chemistry in understanding their biological actions and structure-activity relationships, and new directions for their therapeutic use43
Effects of prior osteoporosis treatment on early treatment response of romosozumab in patients with postmenopausal osteoporosis41
Structural perspective of BMP ligands and signaling40
From genetics to epigenetics to unravel the etiology of adolescent idiopathic scoliosis40
Tetracyclines and bone: Unclear actions with potentially lasting effects40
Circulating miRNAs in bone health and disease39
Lifetime impact of achondroplasia: Current evidence and perspectives on the natural history39
Crosstalk between skeletal and neural tissues is critical for skeletal health38
Bone mineral density and osteoporosis in relation to all-cause and cause-specific mortality in NHANES: A population-based cohort study38
Novel therapeutic approaches for the treatment of achondroplasia37
Radiofrequency Echographic Multi Spectrometry (REMS) for the diagnosis of osteoporosis in a European multicenter clinical context37
Bisphosphonates impair the onset of bone formation at remodeling sites37
Adjuvant therapies for MRONJ: A systematic review36
The multifaced role of HtrA1 in the development of joint and skeletal disorders36
The origins and formation of bone-resorbing osteoclasts36
The treatment gap: The missed opportunities for osteoporosis therapy35
Bariatric surgery and skeletal health: A narrative review and position statement for management by the European Calcified Tissue Society (ECTS)35
0.27628302574158